Larvol Delta - Carina-Biotech-Doses-First-Patient-in-Phase-12a-Clinical-Trial-of-LGR5Targeted-CART-Cell-Therapy

CNA3103 - Carina Biotech

https://www.globenewswire.com/news-release/2023/12/18/2798182/0/en/Carina-Biotech-Doses-First-Patient-in-Phase-1-2a-Clinical-Trial-of-LGR5-Targeted-CAR-T-Cell-Therapy.html

Dec 18, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next